DarioHealth Corp expected to post a loss of 46 cents a share - Earnings Preview

DarioHealth

31/10/2023 18:45

* DarioHealth Corp  DRIO.OQ   DRIO.O  is expected to show a
fall
in quarterly revenue when it reports  results 
    * The New York City-based  company is expected to report  a
19.1% decrease in revenue to $5.342 million from $6.61 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for DarioHealth Corp is
for a
loss of 46 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months. ​
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $8​, above​ its last closing price of $1.39. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.57       -0.52      -0.58     Missed  -11.1
 Mar. 31 2023  -0.49       -0.50      -0.45     Beat    9.6
 Dec. 31 2022  -0.56       -0.65      -0.51     Beat    21.8​
 Sep. 30 2022  -0.71       -0.76      -0.64     Beat    16.1
 ​​Jun.        -0.71       -0.71      -0.74     Missed  -3.9
 30 2022                                                
 Mar. 31 2022  -0.96       -0.96      -0.74     Beat    22.7​
 Dec. 31 2021  -1.09       -1.06      -1.09     Missed  -3.2
 Sep. 30 2021  -0.91       -0.94      -1.18     Missed  -26.1
 This summary was machine generated October 31 at 18:44 GMT.  All
figures in US dollars  unless otherwise stated